AI assistant
Sending…
PFIZER INC — Director's Dealing 2003
Dec 19, 2003
29831_dirs_2003-12-19_fed9ff52-794b-4aed-a3bd-fc59100bf6e9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ARQULE INC (ARQL)
CIK: 0001019695
Period of Report: 2003-12-17
Reporting Person: PFIZER INC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2003-12-17 | Common stock | J | 645162 | $2.67 | Acquired | 3273679 | Indirect |
Footnotes
F1: Shares acquired directly from ArQule as an additional equity investment.
F2: Joint Filer Information
Name: Pfizer Holdings Europe
Address: La Touche House - International Financial Services Centre - Dublin 1, Ireland
Designated Filer: Pfizer Inc.
Issuer and Ticker Symbol: ArQule, Inc. (ARQL)
Date of Event Requiring Statement: December 17, 2003.
Signature: Pfizer Holdings Europe
Signature of Reporting Person: /s/ Brian G. Byala, Director
Date: December 17, 2003
More from PFIZER INC
Major Shareholding Notification
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 5
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
May 1
Regulatory Filings
2026
Apr 27
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31